Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2021-11-21 Share Issue/Capital Cha…
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - AVR 8 pages 29.9KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary shares. It includes specifics about the number of securities, issue dates, and classifications. This is a formal announcement related to capital changes, specifically the issuance and quotation of new shares resulting from option exercises. It does not contain financial statements or performance data, nor is it a report or presentation. Therefore, it fits the category of Share Issue/Capital Change announcements.
2021-11-21 English
Notification of Expiry of Listed Options 5 pages 526.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 17 November 2021 regarding the notification of expiry of listed options (ASX: AVRO) for Anteris Technologies Ltd. It includes detailed instructions to option holders about exercising their options, payment methods, expiry dates, and cessation of official quotation of the options. The document is a formal notification to shareholders about the expiry and exercise process of listed options, not a financial report or earnings release. It does not contain financial statements, management discussion, or audit information. It is also not a proxy solicitation, dividend notice, or capital change announcement. The content is focused on the expiry and exercise of listed options, which relates to capital structure changes but is specifically about the expiry notification and exercise instructions. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2021-11-16 English
Notification regarding unquoted securities - AVR 9 pages 32.2KB
Share Issue/Capital Change Classification · 100% confidence The document is a notification regarding the issue of unquoted equity securities by Anteris Technologies Ltd. It details the number and type of securities issued, including options under an employee incentive scheme, and references ASX listing rules and security codes. The content focuses on the issuance of securities rather than financial results, management changes, or other report types. This fits the category of announcements related to share issues or capital changes. The document length is 7850 characters, which is substantive and contains detailed issuance information, not just a brief announcement or link to a report. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2021-11-15 English
Notice of Extraordinary General Meeting/Proxy Form 23 pages 874.4KB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is an announcement of an Extraordinary General Meeting (EGM) for Anteris Technologies Ltd, including the Notice of Meeting, Explanatory Memorandum, Proxy Voting Form, and related materials. It details the agenda items for shareholder voting, including ratification and approval of prior share issues and options, and approval of future option issues. The document is dated 15 November 2021 and the meeting is scheduled for 16 December 2021. The content is focused on informing shareholders about the meeting and the resolutions to be voted on, rather than reporting financial results or management commentary. It is not a full report but a meeting notice and explanatory materials. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings such as EGMs.
2021-11-14 English
Application for quotation of securities - AVR 8 pages 29.9KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities following the exercise of options or conversion of convertible securities. It details the number of securities to be quoted, issue dates, and the nature of the securities. This is a regulatory announcement related to capital changes, specifically the issuance and quotation of new shares resulting from option exercises. It is not a financial report, earnings release, or management discussion. The document fits the category of Share Issue/Capital Change announcements, as it concerns new securities being issued and quoted on the exchange.
2021-11-14 English
DurAVR selected for PCR London Valves Innovation Session 2 pages 210.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 8 November 2021 from Anteris Technologies Ltd. It announces the company's selection to present at the PCR London Valves Innovation Session, describing the event and the company's product DurAVR. The document is short (2976 characters) and does not contain any financial data, financial results, or detailed report content. It is a corporate announcement about participation in a conference and product recognition, not a financial report, regulatory filing, or management report. It does not fit into categories like Annual Report, Earnings Release, or Investor Presentation. It is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2021-11-07 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.